Light for Renal Transplant Recipients Having a Sleep-Wake Dysregulation (SleepTx-1)
Daily Light Intervention in Renal Transplant Recipients Having a Sleep-Wake Dysregulation
Sponsor: Insel Gruppe AG, University Hospital Bern
A EARLY_PHASE1 clinical study on Renal Disease and Sleep Disorders, this trial is completed. The trial is conducted by Insel Gruppe AG, University Hospital Bern and has accumulated 10 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed EARLY_PHASE1
-
Jul 2023 — Jul 2024 [monthly]
Completed EARLY_PHASE1
-
Jan 2023 — Jul 2023 [monthly]
Completed EARLY_PHASE1
-
Dec 2022 — Jan 2023 [monthly]
Completed EARLY_PHASE1
▶ Show 5 earlier versions
-
Dec 2021 — Dec 2022 [monthly]
Completed EARLY_PHASE1
-
Jan 2021 — Dec 2021 [monthly]
Completed EARLY_PHASE1
-
Jun 2018 — Jan 2021 [monthly]
Completed EARLY_PHASE1
-
Feb 2017 — Jun 2018 [monthly]
Completed EARLY_PHASE1
Phase: Phase 0 → EARLY_PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Completed Phase 0
First recorded
Oct 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Insel Gruppe AG, University Hospital Bern
- University Hospital, Basel, Switzerland
- University Hospital, Zürich
- University of Basel
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.